# OnCo record ibt1116 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ibt1116/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ibt1116" ;
  schema:name "IBT1116"@en ;
  schema:description "IBT1116 is an experimental off-the-shelf immune cell treatment from ImmuneBro Therapeutics for B-cell cancers, including after CAR-T relapse. It has not yet entered trials."@en ;
  schema:url <https://onco.cc/drugs/ibt1116/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.immunebro.com/> ;
  onco:status "preclinical" ;
  onco:tag "pipeline" ;
  onco:modality "Allogeneic engager T cell therapy" ;
  onco:technologies <https://onco.cc/technologies/allogeneic-cell-therapy/> ;
  onco:companies <https://onco.cc/companies/immunebro-therapeutics/> .